| |
| Magyar Immunológiai Társaság |
|
| Szeminárium: Monoklonális ellenanyag alapú proteomika: technológia és alkalmazás |
 Rendezvény kezdete: 2011.11.15. 14:00 | Rendezvény vége: 2011.11.15. 15:00 |
| Helyszín: 6726 Szeged, Temesvári krt. 62., MTA SZBK Genetikai Intézet, Tanácsterem (320. szoba) |
| A rendezvény Web oldala: http://www.szbk.u-szeged.hu/seminars.php |
| Takács László, egyetemi tanár, MTA külső tag, szemináriumi előadást tart |
|
|
 |
| |
| Magyar Hematológiai és Transzfuziológiai Társaság |
|
| 2nd World Congress on Controversies in Hematology (COHEM) |
| Rendezvény kezdete: 2012.09.06. | Rendezvény vége: 2012.09.08. |
| Helyszín: Spain, Barcelona, |
| A rendezvény Web oldala: http://www.comtecmed.com/cohem |
The 2nd World Congress on Controversies in Hematology (COHEM) will be held in Barcelona, Spain on September 6-8, 2012.
Following the great success of The 1st World Congress on Controversies in Hematology (COHEM), which attracted almost 500 participants from more than 60 countries, the 2nd COHEM Congress aims to provide a unique opportunity for world leaders in the field to debate the most vital and contentious issues in benign and malignant Hematology.
This thought-provoking academic dialogue will raise the most challenging current clinical and technological questions.
To learn more about the 2nd COHEM Congress please visit the website:
http://www.comtecmed.com/cohem/2012/ >> |
|
|
|
| |
| Magyar Hematológiai és Transzfuziológiai Társaság |
|
| 2nd World Congress on Controversies in Hematology (COHEM) |
| Rendezvény kezdete: 2012.09.06. | Rendezvény vége: 2012.09.08. |
| Helyszín: Spain, Barcelona, |
| A rendezvény Web oldala: http://www.comtecmed.com/cohem |
The 2nd World Congress on Controversies in Hematology (COHEM) will be held in Barcelona, Spain on September 6-8, 2012.
Following the great success of The 1st World Congress on Controversies in Hematology (COHEM), which attracted almost 500 participants from more than 60 countries, the 2nd COHEM Congress aims to provide a unique opportunity for world leaders in the field to debate the most vital and contentious issues in benign and malignant Hematology.
This thought-provoking academic dialogue will raise the most challenging current clinical and technological questions.
To learn more about the 2nd COHEM Congress please visit the website:
http://www.comtecmed.com/cohem/2012/ >> |
|
|
|
